Targeting the Endocannabinoid System for Treatment of Human Diseases
Event Date: January 27, 2021
Deadline to Submit Abstracts: December 9, 2020
You are invited to submit a poster abstract which will be displayed virtually on our website. See here for submission guidelines.
The endocannabinoid system (ECS) maintains homeostasis in the body by regulating physiologic processes including neurotransmission, mood, energy balance, immune responses, and wound healing. Functions of the ECS are mediated by two cannabinoid receptors, Type 1 and 2 (CB1 and CB2). This meeting will focus on the understanding of the physiology and pharmacology of the peripheral endocannabinoid system. The goal is to illuminate the roles of CB1 and CB2 receptors with regard to possible discovery and development of entirely new classes of drugs for the treatment of inflammatory, immune, and fibrotic disorders.
To register for this event, please visit the main website at: www.nyas.org/ECS21